tert-butyl beta-carboline-3-carboxylate has been researched along with methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate in 5 studies
| Studies (tert-butyl beta-carboline-3-carboxylate) | Trials (tert-butyl beta-carboline-3-carboxylate) | Recent Studies (post-2010) (tert-butyl beta-carboline-3-carboxylate) | Studies (methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate) | Trials (methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate) | Recent Studies (post-2010) (methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate) |
|---|---|---|---|---|---|
| 45 | 0 | 7 | 218 | 0 | 18 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, JM; Cox, ED; Diaz-Arauzo, H; Harris, B; Huang, Q; Ma, C; McKernan, R; Reddy, MS; Skolnick, P | 1 |
| Cook, JM; Dayer, CA; He, X; Huang, Q; Liu, R; Ma, C; McKernan, R; Wenger, GR; Yu, S | 1 |
| Cook, JM; DeLorey, TM; He, X; Lameh, J; Lin, RC; Loew, GH; McBrady, B | 1 |
| Bokonjić, DR; Cook, JM; Obradović, DI; Savić, MM; Ugresić, ND; Yin, W | 1 |
| Bokonjić, DR; Cook, JM; Obradović, DI; Sarma, PV; Savić, MM; Ugresić, ND | 1 |
5 other study(ies) available for tert-butyl beta-carboline-3-carboxylate and methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate
| Article | Year |
|---|---|
Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(benzyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (Zk 93423)
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Binding, Competitive; Carbolines; Cell Line; Cerebral Cortex; Drug Design; GABA Agonists; Humans; Male; Mice; Muscle Relaxation; Rats; Receptors, GABA-A; Recombinant Proteins; Seizures; Structure-Activity Relationship | 1998 |
Pharmacophore/receptor models for GABA(A)/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach.
Topics: Animals; Benzodiazepines; Carbolines; Cell Line; Columbidae; Conditioning, Operant; Crystallography, X-Ray; Humans; Indoles; Ligands; Male; Models, Molecular; Pyrimidines; Quinolones; Radioligand Assay; Receptors, GABA-A; Saimiri; Stereoisomerism; Structure-Activity Relationship | 2000 |
Influence of benzodiazepine binding site ligands on fear-conditioned contextual memory.
Topics: Animals; Azides; Benzodiazepines; Binding Sites; Binding, Competitive; Carbolines; Conditioning, Psychological; Convulsants; Fear; Flumazenil; GABA Antagonists; GABA Modulators; Imidazoles; Ligands; Male; Memory; Mice; Mice, Inbred C57BL; Motor Activity; N-Methylscopolamine; Piperazines; Quinolines; Receptors, GABA-A; Scopolamine; Silanes; Tritium | 2001 |
Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and beta-CCt.
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Binding Sites; Carbolines; Drug Interactions; Flumazenil; GABA Modulators; Ligands; Male; Maze Learning; Mice; Midazolam; Pyridines; Rats; Rats, Wistar; Receptors, GABA-A; Zolpidem | 2004 |
Bidirectional effects of benzodiazepine binding site ligands on active avoidance acquisition and retention: differential antagonism by flumazenil and beta-CCt.
Topics: Animals; Anti-Anxiety Agents; Avoidance Learning; Benzodiazepines; Binding Sites; Carbolines; Convulsants; Dose-Response Relationship, Drug; Flumazenil; GABA Agonists; GABA Modulators; GABA-A Receptor Agonists; Habituation, Psychophysiologic; Injections, Intraperitoneal; Ligands; Male; Midazolam; Motor Activity; Pyridines; Rats; Rats, Wistar; Receptors, GABA-A; Retention, Psychology; Zolpidem | 2005 |